Literature DB >> 8350491

Anticarcinogenic activity of green tea polyphenols.

A Komori1, J Yatsunami, S Okabe, S Abe, K Hara, M Suganuma, S J Kim, H Fujiki.   

Abstract

The main physiologically active polyphenol in green tea extract is (-)-epigallocatechin gallate (EGCG). Green tea extract has an advantage over EGCG as a cancer chemopreventive agent for humans, as is apparent from the Japanese custom of injesting green tea on a daily basis. Green tea extract similarly inhibited protein kinase C activation by teleocidin, a tumor promoter, as did EGCG. In addition, EGCG and green tea extract showed inhibitory effects on the growth of lung and mammary cancer cell lines with similar potencies. An experiment using the estrogen-dependent MCF-7 cell line showed the mechanisms of action of these compounds to be inhibiting the interaction of estrogen with its receptors. Considering our previous results of a single application of EGCG to mouse skin inhibiting the specific binding of 3H-12-0-tetradecanoylphorbol-13-acetate (3H-TPA) and 3H-okadaic acid, we postulated that EGCG and compounds in green tea extracts would block the interaction of tumor promoters, hormones and growth factors with their receptors: a kind of sealing effect. The sealing effect would account for reversible growth arrest, and may be induced by various kinds of compound.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8350491

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  27 in total

1.  Antioxidant properties of (-)-epicatechin-3-gallate and its inhibition of Cr(VI)-induced DNA damage and Cr(IV)- or TPA-stimulated NF-kappaB activation.

Authors:  X Shi; J Ye; S S Leonard; M Ding; V Vallyathan; V Castranova; Y Rojanasakul; Z Dong
Journal:  Mol Cell Biochem       Date:  2000-03       Impact factor: 3.396

Review 2.  Chemoprevention of bladder cancer.

Authors:  Dragan J Golijanin; David Kakiashvili; Ralph R Madeb; Edward M Messing; Seth P Lerner
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

Review 3.  Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea.

Authors:  Y D Jung; L M Ellis
Journal:  Int J Exp Pathol       Date:  2001-12       Impact factor: 1.925

4.  Activity of green tea polyphenol epigallocatechin-3-gallate against ovarian carcinoma cell lines.

Authors:  Yong Wook Kim; Su Mi Bae; Joon Mo Lee; Sung Eun Namkoong; Sei Jun Han; Byoung Rai Lee; Insu P Lee; Sang Hee Kim; Young Joo Lee; Chong Kook Kim; Yong-Wan Kim; Woong Shick Ahn
Journal:  Cancer Res Treat       Date:  2004-10-31       Impact factor: 4.679

Review 5.  Green tea and breast cancer.

Authors:  Anna H Wu; Lesley M Butler
Journal:  Mol Nutr Food Res       Date:  2011-04-29       Impact factor: 5.914

Review 6.  Thermodynamic and kinetic considerations for the reaction of semiquinone radicals to form superoxide and hydrogen peroxide.

Authors:  Yang Song; Garry R Buettner
Journal:  Free Radic Biol Med       Date:  2010-05-21       Impact factor: 7.376

7.  Phytoestrogens regulate mRNA and protein levels of guanine nucleotide-binding protein, beta-1 subunit (GNB1) in MCF-7 cells.

Authors:  Srivatcha Naragoni; Shireesha Sankella; Kinesha Harris; Wesley G Gray
Journal:  J Cell Physiol       Date:  2009-06       Impact factor: 6.384

8.  (-)-Epigallocatechin-3-gallate induces Du145 prostate cancer cell death via downregulation of inhibitor of DNA binding 2, a dominant negative helix-loop-helix protein.

Authors:  Katherine L Luo; Jian-Hua Luo; Yan P Yu
Journal:  Cancer Sci       Date:  2009-11-06       Impact factor: 6.716

Review 9.  Green tea (Camellia sinensis) for the prevention of cancer.

Authors:  Katja Boehm; Francesca Borrelli; Edzard Ernst; Gabi Habacher; Shao Kang Hung; Stefania Milazzo; Markus Horneber
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

10.  Flavonoids uptake and their effect on cell cycle of human colon adenocarcinoma cells (Caco2).

Authors:  M Salucci; L A Stivala; G Maiani; R Bugianesi; V Vannini
Journal:  Br J Cancer       Date:  2002-05-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.